Combination therapy group:None
Sponsors
The First Affiliated Hospital of Army Medical University, The Third Medical Centre, Chinese PLA General Hospital, Beijing, China, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, The First Affiliated Hospital of Guangxi Medical University, Beijing Chao-Yang Hospital, Capital Medical University
Conditions
Chronic HBV infectionNoneRenal cell carcinomaUlcerative colitisVitiligo
Unknown Phase
A prospective cohort study of tofacitinib citrate combined with prednisone acetate in the treatment of advanced non-segmental vitiligo
Active, not recruitingChiCTR2500097209
Start: 2025-02-18Updated: 2025-02-17
A Multi-omics Study of Immune Checkpoint Inhibitors Combined with Tyrosine Kinase Inhibitors in the Treatment of Unresectable/Advanced Renal Cell Carcinoma
Active, not recruitingChiCTR2500110922
Start: 2025-10-31Updated: 2025-10-27
Multicenter, Prospective, Real-World Study of Peg IFNa-2b in the Treatment of Chronic HBV Infection
RecruitingChiCTR2500111862
Start: 2025-07-28Updated: 2025-11-11
Efficacy and safety of amisulpride combined with ondansetron in preventing postoperative nausea and vomiting
Active, not recruitingChiCTR2600120471
Start: 2026-03-31Updated: 2026-03-23
Analysis of Sustained Benefit of Vedolizumab Combined with 5-ASA in the Treatment of Active UC
Active, not recruitingChiCTR2600130556
Start: 2026-09-01Updated: 2026-08-24